Magenta Therapeutics

+$0.82 (+7.78%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MGTA and other stocks, options, and ETFs commission-free!

About MGTA

Magenta Therapeutics, Inc. Common Stock, also called Magenta Therapeutics, is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants.

CEO
Jason Gardner
Employees
69
Headquarters
Cambridge, Massachusetts
Founded
2015

MGTA Key Statistics

Market Cap
600.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
122.27K
High Today
$11.59
Low Today
$10.75
Open Price
$10.88
Volume
150.57K
52 Week High
$14.20
52 Week Low
$6.03

MGTA Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.41 per share
Actual
-$0.36 per share

You May Also Like

EFIV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure